Pamisell has ranked among the top searched stocks for 16 days in the past month.

As of 1:31 PM on the 10th, Pamisell is trading at 22,900 KRW, down 0.22% from the previous day. This marks a 20.21% increase compared to July 14. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreign investors are tentatively recorded as net sellers of 30,000 shares. Over the past five days, individual investors have net sold 564,394 shares, while foreign and institutional investors have net bought 433,176 shares and 70,906 shares, respectively.



[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: Shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing